Our website uses cookies to enhance your browsing experience and to collect information about how you use this site to improve our service to you. By not accepting cookies some elements of the site, such as video, will not work. Please visit our Cookie Policy page for more information on how we use cookies.
Notification to Medical Testing laboratories (Rev 2 October 2019 )
Accreditation according to the Irish Guideline for the Investigation of Blood Culture Samples (Pending revision 2019)
INAB will accredit Medical laboratories according to the Irish Guideline for the Investigation of Blood Cultures. The laboratory shall present its risk assessment (As referred to in the guidelines) for review by the INAB assessment teams. The risk assessment shall ensure the following:
The Turnaround time (TAT) for the blood cultures test is defined clearly and unambiguously by each laboratory. i.e number of hours is defined. Statements such as, ‘as soon as possible’, ‘up to X hours’ etc. shall not be used in the definition of TAT.
Blood culture bottles are loaded to the laboratory testing equipment within four hours from when the sample is taken. (As per the guidelines). Any positive results are reported in accordance with each laboratory stated risk assessed TATs.
The time within which the laboratory will provide a gram stain result is defined clearly and specifically for each laboratory and is reasonable taking into account the patient demographic. The laboratory shall have the capability in place to complete the gram stain. Please also see the note below in relation to PS 23.
The revised blood culture guidelines, due to be issued in 2019, state that ‘aspects of this guideline will be enhanced or replaced by the introduction of molecular techniques’. Verification of such molecular techniques, as part of the Blood Cultures test, may be presented to assessment teams as an extension to scope, using the normal process of application to INAB.
Timeline for ID and susceptibility testing is 24-48 hours. (As per the guidelines.)
The TAT defined by the laboratory shall be approved by Clinical Director / Clinical Lead of the Hospital. i.e. the TAT is fit for purpose and meets the requirement of the users of the service.
Note: The underlying principle that each patient sample is treated equally, irrespective of the time when the sample is taken shall be applied and INAB policy statement PS23 shall be adhered to at all times.
If a laboratory wishes to apply for accreditation using the UK Guidelines for Blood cultures, this will also be considered by the assessment teams.
Please contact your INAB officer if you require more details.